Somchai Rice, MS, Ph D Candidate

Founder and Chief Science Officer

MedBlox, Inc.

Riverside, Iowa United States


Iowa State University

About Me

Somchai is a co-founder and Chief Science Officer of MedBlox. She believes in the shared goal of removing data biases, barriers of entry, and enabling the continuous iteration (CI)-age of healthcare. Somchai worked over a decade in the areas of analytical chemistry and instrumentation, research, and veterinary diagnostic and animal production medicine. Somchai’s successful career in academia produced 14 peer reviewed publications, 23 oral presentations, posters, and sponsor reports. Somchai easily parlays this knowledge from classroom teaching at the university level to extension and outreach workshops to industry and lay people.

You have not backed any projects. Lets change that!
Discover Projects

  • Project : Healthcare Innovation via Patient Centric Interoperability

    Comment : Thanks for the support, Dr. Baqui!

    Posted on : 8th October, 2018
  • Project : Healthcare Innovation via Patient Centric Interoperability

    Comment : Thanks for the support, Jenah!

    Posted on : 8th October, 2018
  • No data found. Lets change that!
    Discover Projects

    No data found. Lets change that!
    Discover Projects

    No data found. Lets change that!
    Discover Projects

    No data found. Lets change that!
    Discover Projects

    No data found. Lets change that!
    Discover Projects

    No data found. Lets change that!
    Discover Projects

    No project reviewed yet. Lets change that!
    Discover Projects

    Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.